$HCM Cashflow Statement | Understand Stock

$HCM

$13.32 -$0.48 (3.48%) Close

$HCM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net cash (used in)/generated from operating activities
Investing activities
Purchases of property, plant and equipment
Purchase of leasehold land
Proceeds from disposal of property, plant and equipment
Refund of leasehold land deposit
Deposits in short-term investments
Proceeds from short-term investments
Purchase of a warrant
Dividend and proceeds received from divestment of Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited ("HBYS")
Proceeds from divestment of other equity investee
Acquisition of an intangible asset
Cash disposed from divestment of subsidiaries
Net cash used in investing activities

Financing activities
Purchases of treasury shares
Dividends paid to non-controlling shareholders of subsidiaries
Repayment of loan to a non-controlling shareholder of a subsidiary
Proceeds from bank borrowings
Repayment of bank borrowings
Net cash generated from/(used in) financing activities

Net decrease in cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents, including effect of exchange rate changes
Cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosure for cash flow information
Cash paid for interest
Cash paid for tax, net of refunds
Supplemental disclosure for non-cash activities
(Decrease)/increase in accrued capital expenditures
Vesting of treasury shares for LTIP

Comments